Hudson Bay Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.6M Sell
30,000
-15,000
-33% -$1.44M 0.01% 695
2025
Q4
$4.32M Buy
45,000
+41,315
+1,121% +$4.01M 0.01% 543
2025
Q3
$351K Sell
3,685
-9,599
-72% -$882K ﹤0.01% 954
2025
Q2
$1.16M Sell
13,284
-30,662
-70% -$2.6M ﹤0.01% 931
2025
Q1
$3.95M Buy
+43,946
New +$3.93M 0.01% 664
2022
Q1
Sell
-10,000
Closed -$1.03M 1262
2021
Q4
$1.03M Buy
+10,000
New +$1.16M 0.01% 787
2020
Q1
Sell
-65,000
Closed -$7.37M 556
2019
Q4
$7.37M Sell
65,000
-135,000
-68% -$14.8M 0.16% 120
2019
Q3
$21.7M Buy
200,000
+100,000
+100% +$10.4M 0.6% 31
2019
Q2
$9.74M Buy
+100,000
New +$9.13M 0.22% 90
2017
Q3
Sell
-164,162
Closed -$14.6M 472
2017
Q2
$14.6M Buy
164,162
+121,562
+285% +$10.3M 0.29% 79
2017
Q1
$3.43M Buy
+42,600
New +$3.33M 0.05% 343
2014
Q4
Sell
-110,116
Closed -$6.82M 208
2014
Q3
$6.82M Buy
+110,116
New +$7M 0.19% 86

Other funds holding MDT

Hudson Bay Capital Management's MDT Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Medtronic (MDT) stake by 33% in Q1 2026, selling an estimated $1.44M and leaving 30,000 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #695.

Hudson Bay Capital Management first reported a position in MDT in Q3 2014 and has held it in 12 quarters since. The position peaked at $21.7M in Q3 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Hudson Bay Capital Management held 30,000 shares of Medtronic worth $2.6M as of Q1 2026.
  • Hudson Bay Capital Management sold 15,000 Medtronic shares in Q1 2026, an estimated $1.44M.
  • Medtronic made up 0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #695 holding.
  • Hudson Bay Capital Management first reported a position in Medtronic in Q3 2014 and has held it in 12 quarters since.
  • Hudson Bay Capital Management's Medtronic position peaked at $21.7M in Q3 2019.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.